Trade GPCR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Structure Therapeutics Inc. American Depositary Shares (GPCR) is trading at US$26.68, down 2.88% today as of Oct 7, 16:00 EDT. The company has a market capitalisation of US$3.5B. Over the past 52 weeks, GPCR has traded between US$25.59 and US$94.90. On Syfe you can trade GPCR with $0 commission and add it to your watchlist.
| Previous close | US$27.47 |
|---|---|
| Market cap | US$3.5B |
| 52-week range | US$25.59 – US$94.90 |
| Volume | 1.05M |
| Exchange | US |
Structure Therapeutics Inc. American Depositary Shares
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.
Year: 2023
Canaccord Genuity Initiates Coverage on Structure Therapeutics With Buy Rating, $101 Price Target
Apr 27, 11:44 AM · MT Newswires
Structure Therapeutics Names Matthew Lang as COO
Apr 14, 8:21 PM · MT Newswires
Stay on top of GPCR
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
